An Updated Review on Psoriasis and Surgery
Main Article Content
Abstract
Psoriasis is a chronic inflammatory skin disease with a complex pathogenesis involving the interaction between the innate and adaptive immune systems. The release of antimicrobial peptides (AMPs) by keratinocytes, particularly LL-37 peptides, plays a crucial role in the initiation of psoriatic inflammation. The activation of dendritic cells and distinct T-cell subsets, particularly Th1 and Th17, leads to the formation of scaly plaques in psoriasis. Although most cases are treated with topical or systemic medications, severe forms such as pustular psoriasis and psoriatic arthritis may require surgical management. Surgical procedures aim to relieve symptoms, improve function, and minimize scarring and cosmetic deformities. However, psoriatic patients are at higher risk of post-surgical infections and surgical stress may trigger psoriatic flare-ups. Thus, meticulous post-surgical wound care and psychological support are essential for optimal outcomes.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. International Journal of Molecular Sciences. 2019;20(6):1475.
II. Guidelines for the diagnosis and treatment of psoriasis in China: 2019 Concise edition#. International Journal of Dermatology and Venereology. 2020;3(1):14–26.
III. Langley RG. Psoriasis: Epidemiology, clinical features, and quality of life. Annals of the Rheumatic Diseases. 2005;64(suppl_2):ii18–ii23.
IV. Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021 Feb;84(2):432-470. DOI: 10.1016/j.jaad.2020.07.087.
V. Walter K. Psoriasis. JAMA. 2022;327(19):1936.
VI. Di Meglio P, Villanova F, Nestle FO. Psoriasis. Cold Spring Harb Perspect Med. 2014 Aug 1;4(8):a015354. DOI: 10.1101/cshperspect.a015354.
VII. Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: A comprehensive review. J Autoimmun. 2015 Nov;64:66-73. DOI: 10.1016/j.jaut.2015.07.008.
VIII. Morizane S, Gallo RL. Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol. 2012 Mar;39(3):225-30. DOI: 10.1111/j.1346-8138.2011.01483.x.
IX. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005 Jul 4;202(1):135-43. DOI: 10.1084/jem.20050500.
X. Morizane S, Yamasaki K, Mühleisen B, Kotol PF, Murakami M, Aoyama Y, et al. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol. 2012 Jan;132(1):135-43. DOI: 10.1038/jid.2011.259.
XI. Gregorio J, Meller S, Conrad C, Di Nardo A, Homey B, Lauerma A, et al. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med. 2010 Dec 20;207(13):2921-30. DOI: 10.1084/jem.20101102.
XII. Hänsel A, Günther C, Ingwersen J, Starke J, Schmitz M, Bachmann M, et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9. DOI: 10.1016/j.jaci.2010.12.009.
XIII. Santini SM, Lapenta C, Donati S, Spadaro F, Belardelli F, Ferrantini M. Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12. PLoS One. 2011 Feb 28;6(2):e17364. DOI: 10.1371/journal.pone.0017364.
XIV. Nestle FO, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest. 1994 Jul;94(1):202-9. DOI: 10.1172/JCI117308.
XV. Genovese G, Moltrasio C, Cassano N, Maronese CA, Vena GA, Marzano AV. Pustular psoriasis: From pathophysiology to treatment. Biomedicines. 2021 Nov 23;9(12):1746. DOI: 10.3390/biomedicines9121746.
XVI. Varman KM, Namias N, Schulman CI, Pizano LR. Acute generalized pustular psoriasis, von Zumbusch type, treated in the burn unit. A review of clinical features and new therapeutics. Burns. 2014 Jun;40(4):e35-9. DOI: 10.1016/j.burns.2014.01.003.
XVII. Haque N, Lories RJ, de Vlam K. Orthopaedic interventions in patients with psoriatic arthritis: a descriptive report from the SPAR cohort. RMD Open. 2016 Aug 17;2(2):e000293. DOI: 10.1136/rmdopen-2016-000293.
XVIII. Genga EK, Nalawade A, Oyoo GO. Perioperative management of patients with psoriatic arthritis: Case report and literature review [Internet]. East African Orthopaedic Journal. [cited 2023Apr29]. Available from: https://www.ajol.info/index.php/eaoj/article/view/120359
XIX. Lian Q, Lian Y, Li K, Yang Q, Li K, Zheng Y, et al. Complications of primary total hip arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and primary osteoarthritis. BMC Musculoskelet Disord. 2022 Oct 19;23(1):924. DOI: 10.1186/s12891-022-05891-9.
XX. Constantin MM, Ciurduc MD, Bucur S, Olteanu R, Ionescu RA, Constantin T, et al Psoriasis beyond the skin: Ophthalmological changes (Review). Exp Ther Med. 2021 Sep;22(3):981. DOI: 10.3892/etm.2021.10413.
XXI. Shainhouse T. Ocular Manifestations of Psoriasis [Internet]. ECRONICON Open Access. 2017 [cited 2023Apr29]. Available from: https://www.ecronicon.com/ecop/pdf/ECOP-05-00142.pdf
XXII. Gracitelli CP, Osaki TH, Valdrighi NY, Viana GA, Osaki MH. Cicatricial ectropion secondary to psoriatic arthritis. Case Rep Ophthalmol Med. 2015;2015:315465. DOI: 10.1155/2015/315465.
XXIII. Köse B, Uzlu D, Erdöl H. Psoriasis and uveitis. Int Ophthalmol. 2022 Jul;42(7):2303-2310. DOI: 10.1007/s10792-022-02225-5.
XXIV. Cheng CY. Risk of incident cataract in patients with psoriasis: A population-based cohort study. J Dermatol. 2022 Mar;49(3):359-367. DOI: 10.1111/1346-8138.16261.
XXV. Doumazos S, Kandarakis SA, Petrou P, Karagiannis D, Doumazos L, Georgalas I. Posterior scleritis in a patient with psoriasis masquerading as acute angle closure glaucoma. Case Rep Ophthalmol. 2022 Sep 30;13(3):717-723. DOI: 10.1159/000526714.
XXVI. Dai YX, Tai YH, Lee DD, Chang YT, Chen TJ, Chen MH. Risk of retinal diseases in patients with psoriasis: A population-based cohort study in Taiwan. J Dermatol. 2021 Oct;48(10):1550-1556. DOI: 10.1111/1346-8138.16062.
XXVII. Wen J, Hu H, Chen M, Yang H, Zhao Y, Liu Y. Role of Janus Kinase (JAK) inhibitor in autoimmune ocular inflammation: A systematic review. J Immunol Res. 2021 Dec 20;2021:2324400. DOI: 10.1155/2021/2324400.
XXVIII. Nottrott M, Hardes J, Winkelmann W, Gosheger G. Wound healing in a patient with psoriasis vulgaris and femur megaprosthesis implantation. Sarcoma. 2008;2008:509242. DOI: 10.1155/2008/509242.
XXIX. Padua R, Aulisa L, Padua L, Ceccarelli E, Sgrambiglia R, Padua S. Two cases of surgical complication in patients affected by lumbar disc herniation and psoriasis. Journal of Orthopaedics and Traumatology. 2000;1(1):63–6.
XXX. Piantoni L, Tello CA, Remondino RG, Wilson IAF, Galaretto E, Bersusky ES, Noel MA. Antibiotic prophylaxis in high-risk pediatric spine surgery: Is cefazolin enough? Spine Deform. 2020 Aug;8(4):669-676. DOI: 10.1007/s43390-020-00092-7.
XXXI. Crawford T, Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis? Clin Infect Dis. 2012 May;54(10):1474-9. DOI: 10.1093/cid/cis027.